Skip to main content
. 2024 Jan 3;9:100098. doi: 10.1016/j.obpill.2023.100098

Table 1.

Background characteristics.

Before LSG
Age (Y) 47.2 ± 8.7
Gender (male/female) 17/12
Height (cm) 166.2 ± 9.3
BW (kg) 129.1 ± 35.9
BMI (kg/m2) 46.5 ± 11.0
VFA (cm2) 210.3 (166.2–292.0)
SFA (cm2) 495.9 (425.3–666.7)
Skeletal muscle ratio (%) 28.0 (26.3–29.9)
Systolic BP (mm Hg) 137.3 ± 13.0
Diastolic BP (mm Hg) 81.1 ± 8.3
Fasting glucose (mg/dl) 112.5 (101.3–134.0)
HbA1c (%) 7.0 ± 1.4
CPR (ng/ml) 3.4 (2.5–4.1)
TC (mg/dL) 179.3 ± 41.3
TG (mg/dL) 155.0 (106.5–189.3)
HDL-C (mg/dL) 39.4 ± 8.6
AST (IU/L) 33.5 (26.3–40.8)
ALT (IU/L) 43.5 (26.5–54.3)
Cr (mg/dL) 0.8 (0.6–0.9)
Urinary albumin (mg/gCr) 16.9 (5.1–51.3)
Uric acid (mg/dL) 6.5 (5.7–7.7)
Hb (g/dl) 14.2 ± 1.9
Alb (g/dl) 4.2 ± 0.4
ChE (IU/L) 379.0 ± 82.6
Vitamin B1 (μg/dl) 4.8 (4.3–5.7)
Vitamin B12 (pg/dl) 447.0 (364.8–559.0)
Folic Acid (ng/ml) 9.7 (5.9–13.4)
Vitamin D (ng/ml) 13.6 (11.1–16.5)
Zinc (μg/dl) 71.5 (64.3–77.5)
Iron (mg/dl) 82.5 (68.5–109.5)

Data are presented as mean ± SD or median (interquartile range). BW, body weight; BMI, body mass index; VFA, Visceral fat area; SFA, subcutaneous fat area; FBG, fasting blood glucose; HbA1c, glycosylated hemoglobin; CPR, C peptide immunoreactivity; TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; AST, aspartate aminotransferase; ALT, alanine aminotransferase; Cr, creatinine; Hb, hemoglobin; Alb, albumin; ChE, cholinesterase.